Autoimmune Diseases  >>  AcellBia (rituximab biosimilar)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AcellBia (rituximab biosimilar) / Biocad, Kocak Farma
BIORA, NCT01759030: Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis

Completed
3
181
RoW
Rituximab, MabThera, Rituxan, BCD-020
Biocad
Rheumatoid Arthritis
07/15
07/15
ALTERRA, NCT02744196: Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis

Checkmark EULAR 2016
Jun 2016 - Jun 2016: EULAR 2016
Completed
3
159
NA
Acellbia, rituximab, Placebo, Methotrexate
Biocad
Rheumatoid Arthritis
02/17
08/17

Download Options